Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Heart Test Laboratories Inc. (NASDAQ: HSCS) closed the day trading at $0.10 down -2.50% from the previous closing price of $0.10. In other words, the price has decreased by -$2.50 from its previous closing price. On the day, 1.61 million shares were traded. HSCS stock price reached its highest trading level at $0.1016 during the session, while it also had its lowest trading level at $0.0936.
Ratios:
For a better understanding of HSCS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.32 and its Current Ratio is at 4.71. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.05.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HSCS now has a Market Capitalization of 6385700 and an Enterprise Value of 368763. For the stock, the TTM Price-to-Sale (P/S) ratio is 319.28 while its Price-to-Book (P/B) ratio in mrq is 0.72. Its current Enterprise Value per Revenue stands at 19.826 whereas that against EBITDA is -0.061.
Stock Price History:
The Beta on a monthly basis for HSCS is 3.37, which has changed by -0.8852071 over the last 52 weeks, in comparison to a change of 0.22363698 over the same period for the S&P500. Over the past 52 weeks, HSCS has reached a high of $1.32, while it has fallen to a 52-week low of $0.09. The 50-Day Moving Average of the stock is -16.59%, while the 200-Day Moving Average is calculated to be -71.71%.
Shares Statistics:
Over the past 3-months, HSCS traded about 1.96M shares per day on average, while over the past 10 days, HSCS traded about 4078140 shares per day. A total of 65.56M shares are outstanding, with a floating share count of 54.96M. Insiders hold about 16.16% of the company’s shares, while institutions hold 1.84% stake in the company. Shares short for HSCS as of 1713139200 were 599631 with a Short Ratio of 0.31, compared to 1710460800 on 506019. Therefore, it implies a Short% of Shares Outstanding of 599631 and a Short% of Float of 0.9299999999999999.
Earnings Estimates
A comprehensive evaluation of Heart Test Laboratories Inc. (HSCS) is underway, with the input of 2.0 analysts contributing to its current rating.On average, analysts expect EPS of -$0.03 for the current quarter, with a high estimate of -$0.03 and a low estimate of -$0.04, while EPS last year was -$0.21. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.02 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.19 and -$0.21 for the fiscal current year, implying an average EPS of -$0.2. EPS for the following year is -$0.1, with 2.0 analysts recommending between -$0.09 and -$0.12.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $200k. There is a high estimate of $300k for the next quarter, whereas the lowest estimate is $100k.
A total of 2 analysts have provided revenue estimates for HSCS’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $20k, resulting in an average revenue estimate of $60k. In the same quarter a year ago, actual revenue was $5kBased on 2 analysts’ estimates, the company’s revenue will be $1.9M in the next fiscal year. The high estimate is $3.2M and the low estimate is $600k.
